INTRODUCTION
Middle ear cholesteatoma is a very serious pathology which results from proliferation of epithelial tissues. The reasons for the extension into the middle ear and aetiology of cholesteatotoma are yet to be fully understood [1] . However, it is believed that the epithelium proliferates due to some growth stimulus, leading to chronic inflammation [2] . A few studies reported the involvement of infections in the onset of cholesteatoma. However, many other studies have suggested the involvement of inflammatory cytokines [3] . Cholesteatoma causes serious bone destruction during its proliferation, and the current treatment strategies are not only insufficiently effective, but are also associated with several side effects [4] . Natural products are considered important sources of compounds that can be utilized for the management cholesteatoma. A number of currently used drugs are derived from natural sources and new drugs from natural sources are being frequently discovered [5] . Moreover, compounds derived from natural sources are thought to be comparatively less toxic than their synthetic counterparts [6] . Plants are important sources of drugs. Indeed, a number of drugs currently used in clinics have their origins in plants [5] .
Clitoriaternatea L. (butterfly pea) is an important medicinal plant and a source of some important bioactive compounds. It has been utilised in the management of numerous diseases and disorders such as chronic bronchitis, goitre, leprosy, mucous and dropsy [7, 8] . The roots of this plant are important sources of two important compounds taraxerol and taraxerone. Taraxerol is a pharmacologically important compound that has been reported to exhibit tremendous pharmacological activities which include antitumour, antimicrobial and anti-inflammatory properties [9] .
This investigation was performed to find out the impact of taraxerol on cultured human middle ear epithelial cholesteatoma cells. 
EXPERIMENTAL Cell cultures, chemicals and regents

Cultured
Anti-proliferative and colony formation assays
The impact of taraxerol on the proliferation of human middle ear epithelial cholesteatoma cells was investigated by CCK8 assay. The cells (5×10 3 ) were grown in a ninety-six well plate and subjected to incubation at 37 °C in an atmosphere of 5% CO 2 . Following this, the cells were administrated with various doses of taraxerol (0, 7.5, 15, and 30 μM) for overnight. Thereafter, the addition of CCK8 (10 μL) was done and incubated at 37 °C for 50 min. The optical density of each well's content was read at 450 nm using a microplate spectrophotometer.
Cell proliferation calculated as percentage of the control.
Colony formation assay
Cultured human middle ear epithelial cholesteatoma cells were seeded at 200 cells/well. Thereafter, the cells were incubated for 48 h to allow for attachment, after which they were exposed to different doses (0, 7.5, 15 and 30 µM) of taraxerol. The cells were then subjected to incubation for 6 days, and thereafter washed with PBS, and treated with methanol for colony fixation. The crystal violet staining of the colonies was performed for about 30 min, and counted under the light microscope as described previously [10] .
Apoptosis assay
The cholesteatoma epithelial cells were grown at 2 10 5 cell density per well in ninety six-well plates and subjected to treatment with varied doses of taraxerol (0, 7.5, 15, and 30 μM), followed by incubation for 24h. They were then stained with DAPI, and there after subjected to PBS washing and then fixed in formaldehyde (10 %). The DAPI-stained cells were then observed and photography under a fluorescent microscope as described previously [11] .
Determination of mitochondrial membrane potential
Mitochondrial membrane potential of the middle ear epithelial cholesteatoma cells was studied using confocal microscopy, following staining with rhodamine123 (Rh123). Taraxerol-treated and cultured cells at a density of 2 × 10 5 /mL/well were grown in six-well plates and incubated for 24 h. This was followed by trypsinization and washing with PBS and then re-suspended in the medium and stained with rhodamine 123, followed by incubation for 25 min at 37
Thereafter the cells were collected and washed with PBS, and then finally examined using a laser scanning confocal microscope as described previously [12] .
Cell cycle analysis
To investigate the distribution of middle ear epithelial cholesteatoma cells in various cell cycle phases, the taraxerol-treated (0, 7.5, 15, and 30 μM) cells were collected and twice subjected to PBS washing. This was followed by fixation of the cells in ethanol (70 %) for 1 h. The cells were finally re-suspended in propidium iodide solution (50 µl/mL) and RNase1 (250µg/mL) and then subjected to incubation for ○ C. Finally, the dissemination of the cells in various phases of cell cycle was estimated using fluorescence-activated cell sorting cater-plus cytometer at 10,000 cells/group as described previously [13] .
Western blotting
Taraxerol-treated ear epithelial cholesteatoma cells were lysed in lysis buffer, and proteins were harvested. The concentration of proteins in each sample was determined by BCA assay, and Western blotting was carried out as described previously [1] .
Statistical analysis
Data were shown as mean (of three biological replicates) ± SD. Statistical analysis was performed using student's t test by GraphPad prism 7software. Values of p<0.01 were taken as indicative of statistically significant differences.
RESULTS
Taraxerol exerted anti-proliferative effects on epithelial cholesteatoma cells
The results obtained showed that taraxerol inhibited the proliferation of middle ear epithelial cholesteatoma cells in a concentrationdependent fashion (Figures 1 B -C) .
Taraxerol inhibited colony formation of epithelial cholesteatoma cells
The colony formation potential of cultured middle ear epithelial cholesteatoma cells were significantly and dose-dependently inhibited by taraxerol (p < 0.01, Figure 2 A and B) .
Taraxerol induced apoptosis in epithelial cholesteatoma cells
Taraxerol induced apoptosis in epithelial cholesteatoma cells as obvious from the development of apoptotic crops and cell blebbing ( Figure 3A) . Moreover, the apoptosis-inducing potential of taraxerol was concentrationdependent, and the apoptotic cell percentage cells significantly (p < 0.01) enhanced with increase in taraxerol concentration (Figure 3 B) .
Taraxerol reduced mitochondrial membrane potential of epithelial cholesteatoma cells
Taraxerol reduced mitochondrial membrane potential in a concentration-dependent manner (Figure 4 A -B ).
Taraxerol triggered cell cycle arrest in epithelial cholesteatoma cells
It was observed that taraxerol caused significant enhancement in the sub-G1 cell populations of the cells, ultimately leading to sub-G1 cell cycle arrest. These effects of taraxerol were also concentration-dependent ( Figure 5 ).
Taraxerol suppressed Nf-kB expression in epithelial cholesteatoma cells
The effect of taraxerol on the expression of Nf-kB was investigated by western blotting. The results showed that taraxerol down-regulated the expression of Nf-kB in middle ear cholesteatoma epithelial cells in a concentration-dependent manner ( Figure 6 ). 
DISCUSSION
Middle ear cholesteatoma is caused by proliferation of epithelial tissues, resulting in serious complications. The aetiology of this pathological condition is not well understood [1, 2] . Moreover, the current treatments are not satisfactory, and are associated with side-effects [3] . Therefore, it is believed that development of new effective treatment options with minimal side-effects may prove beneficial. Natural products have a long history of being used for the treatment of several diseases and disorders [5] . In different systems of medicine including Chinese system of traditional medicine, Ayurveda and Unani medicine, different plant extracts and decoctions are used to treat a diversity of pathological conditions [6] . In most of the cases, treatments based on these traditional remedies have produced very effective outcomes. Indeed, researchers across the globe have used the knowledge from these traditional systems to isolate compounds that are effective in the treatment of several diseases and disorders [5] .
Several compounds that are currently used as drugs were isolated from plants. For instance, podophyllotoxin, artemisinin and several other drugs were isolated from plants, and have shown tremendous therapeutic potential [5, 6] . As part of the search program for natural bioactive compounds that can inhibit the proliferation of middle ear epithelial cholesteatoma cells, the present study was focussed on the antiproliferative effects of taraxerol.
Preliminarily, the anti-proliferative effect of taraxerol on ear epithelial cholesteatoma cells was evaluated by CCK8 and clonogenic assays. The results clearly showed that taraxerol suppressed the proliferation of these cells dosedependently. Furthermore, results from colony formation assay complimented the results of CCK8 assay, and showed that taraxerol inhibited the colony-forming potential of the epithelial cholesteatoma cells. These results are in agreement with the results reported in a previous study wherein taraxerol was shown to inhibit the proliferation of several cancerous cells [14, 15] .
It has been reported that anti-proliferative agents inhibit the growth of the cells through apoptosis and cell cycle arrest, which are two important mechanisms that have been found effective in the elimination of the malignant and harmful cells [16, 17] . Therefore, in the present study, investigation was carried out to see if taraxerol could induce apoptosis in epithelial cholesteatoma cells. Interestingly, it was shown that taraxerol triggered apoptosis in cholesteatoma epithelial cells in a dose dependent manner.
To investigate if this apoptosis follows mitochondrial pathway, mitochondrial membrane potential levels were also evaluated. The results showed that taraxerol reduced mitochondrial membrane potential dose-dependently. Previous investigations have also indicated that taraxerol prompts apoptosis in human gastric epithelial cells [18] . In the present study, it was observed that treatment of the epithelial cholesteatoma cells with taraxerol caused considerable accumulation of the cells in sub-G1 phase of the cell cycle, resulting in sub-G1 cell cycle arrest. Several anti-proliferative agents have been reported to induce cell cycle arrest in human cells [16, 19] .
In addition, it has been observed that Nf-kB signalling pathway is upregulated in cholesteatoma epithelial cells and could prove to be an important therapeutic target [20] . Therefore the effect of taraxerol on the expression of Nf-kB was investigated by western blot analysis, and the results showed that taraxerol suppressed the expression of Nf-kB in a concentrationdependent manner.
CONCLUSION
The results obtained in this study indicate that taraxerol triggers apoptosis and cell cycle arrest in middle ear epithelial cholesteatoma by inhibiting the expression of Nf-kB. Hence, taraxerol may be beneficial in the management of amiddle ear cholesteatoma. 
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